share_log

6-K: Report of foreign private issuer (related to financial reporting)

6-K: Report of foreign private issuer (related to financial reporting)

6-K:外國發行人報告(業績相關)
美股SEC公告 ·  11/01 05:01

牛牛AI助理已提取核心訊息

On October 31, 2024, NeuroSense Therapeutics Ltd., a foreign private issuer, announced the signing of a Standby Equity Purchase Agreement with YA II PN, LTD., a Cayman Islands exempt limited partnership also known as Yorkville. Under the terms of the agreement, NeuroSense has the option, but no obligation, to sell up to $30 million of its ordinary shares to Yorkville over a 36-month period. The sale price for the shares will be set at 97% of the lowest daily VWAP on the Nasdaq Stock Market over a specified three-day period following the company's notice to Yorkville. Additionally, NeuroSense has issued 224,697 ordinary shares to Yorkville as a commitment fee and paid a $25,000 structuring fee. The agreement stipulates that Yorkville's ownership cannot exceed...Show More
On October 31, 2024, NeuroSense Therapeutics Ltd., a foreign private issuer, announced the signing of a Standby Equity Purchase Agreement with YA II PN, LTD., a Cayman Islands exempt limited partnership also known as Yorkville. Under the terms of the agreement, NeuroSense has the option, but no obligation, to sell up to $30 million of its ordinary shares to Yorkville over a 36-month period. The sale price for the shares will be set at 97% of the lowest daily VWAP on the Nasdaq Stock Market over a specified three-day period following the company's notice to Yorkville. Additionally, NeuroSense has issued 224,697 ordinary shares to Yorkville as a commitment fee and paid a $25,000 structuring fee. The agreement stipulates that Yorkville's ownership cannot exceed 4.99% of NeuroSense's outstanding shares. The transaction is contingent upon the SEC declaring effective a registration statement for the shares involved. The shares are being offered under an exemption from registration requirements and are not to be sold or offered in the U.S. without registration or an applicable exemption. The agreement includes customary representations, warranties, and conditions.
2024年10月31日,外國私募發行商NeuroSense Therapeutics Ltd.宣佈與開曼群島免稅有限合夥企業YA II PN, LTD.(也被稱爲Yorkville)簽署了備用股權購買協議。根據協議的條款,NeuroSense有權利但無義務在36個月內向Yorkville賣出最多3000萬美元的普通股。股票的銷售價格將以納斯達克股票市場指定三天內最低日均成交價格的97%確定,該價格將在公司向Yorkville發出通知後的指定三天期間內確定。此外,NeuroSense已向Yorkville發行了224,697股普通股作爲承諾費,並支付了25,000美元的結構費。協議規定Yorkville的持股比例不得超過NeuroSense未流通股的4.99%。該交易取決於SEC宣佈對所涉股票的註冊聲明生效。這些股票是在符合註冊要求的豁免情況下提供的,並且不得在未經註冊或適用豁免的情況下在美國銷售或提供。協議包括慣例的陳述、保證和條件。
2024年10月31日,外國私募發行商NeuroSense Therapeutics Ltd.宣佈與開曼群島免稅有限合夥企業YA II PN, LTD.(也被稱爲Yorkville)簽署了備用股權購買協議。根據協議的條款,NeuroSense有權利但無義務在36個月內向Yorkville賣出最多3000萬美元的普通股。股票的銷售價格將以納斯達克股票市場指定三天內最低日均成交價格的97%確定,該價格將在公司向Yorkville發出通知後的指定三天期間內確定。此外,NeuroSense已向Yorkville發行了224,697股普通股作爲承諾費,並支付了25,000美元的結構費。協議規定Yorkville的持股比例不得超過NeuroSense未流通股的4.99%。該交易取決於SEC宣佈對所涉股票的註冊聲明生效。這些股票是在符合註冊要求的豁免情況下提供的,並且不得在未經註冊或適用豁免的情況下在美國銷售或提供。協議包括慣例的陳述、保證和條件。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。